Objectives To prospectively assess rates and detailed predictors of morbidity and mortality among HIVexposed uninfected children and HIV-unexposed children in Botswana in a more recent era.
G lobal scale-up of services to prevent mother-to-child transmission (PMTCT) of HIV-1 has resulted in marked reduction of vertical transmission of HIV-1 from mothers to children. The Joint United Nations Program on HIV and AIDS reported a 60% reduction in the number of children newly infected with HIV between 2009 and 2015 in 21 priority countries, with the highest burden in Sub-Saharan Africa. [1] [2] [3] It is expected that the number of new infections among children will further decrease globally as countries in this region continue to expand their PMTCT services. Globally, more than 1 million HIV-exposed uninfected children were born in 2014. 4 Evidence suggests that HIV exposure results in higher rates of morbidity and mortality in HIV-exposed uninfected children compared with HIV-unexposed children, even when they are breastfed for some period. [5] [6] [7] Several factors are thought to contribute to this increased vulnerability in HIV-exposed uninfected children, including altered child immunity, maternal HIV-related illness, higher rates of adverse pregnancy outcomes such as preterm delivery, shorter duration of breastfeeding, and psychosocial and socioeconomic stressors among HIVinfected women. [8] [9] [10] [11] [12] [13] [14] However, no published studies to date have systematically and concomitantly examined detailed biomedical and psychosocial predictors of mortality in HIV-exposed uninfected vs HIV-unexposed children.
Over the last decade, access to 3-drug (combination) antiretroviral therapy (ART) has increased dramatically, including in pregnant women. 15 ART is expected to 
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improve the health of HIV-positive women and potentially improve their quality of life and socioeconomic status. However, it is unknown whether higher morbidity and mortality previously observed in HIV-exposed uninfected children (compared with HIV-unexposed children) persists with improved maternal health brought about by access to ART.
We, therefore, compared rates of 2-year morbidity and mortality in HIV-exposed uninfected vs HIV-unexposed children in Botswana to assess outcomes in an era when maternal ART was available to women based on CD4 and clinical disease stage criteria. We also prospectively assessed detailed social and economic predictors of childhood morbidity and mortality, in an attempt to determine the most important current predictors of morbidity and mortality among HIV-exposed uninfected children under the age of 2 years in this resourceconstrained setting.
Methods
The Tshipidi study was a prospective observational study comparing health and neurodevelopmental outcomes among HIVexposed uninfected vs HIV-unexposed children from birth through 24 months of age. The study design and evaluation of neurodevelopmental outcomes have been presented previously. 16 Study participants included HIV-infected and HIVuninfected mothers and their liveborn children, enrolled in Gaborone (city) and Mochudi (village) in Botswana between May 2010 and July 2012. Residents of the village (Mochudi) were less likely to have completed tertiary education, be employed, or have a monthly wage of >$100 per month compared with urban residents of Gaborone.
Twins were included; stillborn and HIV-infected infants and their mothers were excluded from this analysis. Mothers met the inclusion criteria of being ≥18 years of age, Botswana citizens, able/willing to provide informed consent, and were either pregnant or within 7 days postpartum at the time of enrollment. Maternal HIV status was first assessed with a rapid HIV test. A positive rapid HIV test was confirmed by a second positive HIV test result obtained by trained study staff at the clinic or reference laboratory by rapid HIV test, any licensed enzyme immunoassay (EIA) test kit, a Western blot, or detectable HIV-1 RNA. Plasma HIV-1 RNA was examined to provide final verification of discordant test results.
Study Procedures and Data Collection
Study visits occurred monthly during pregnancy; at delivery; and at 1, 6, 12, 18, and 24 months postpartum. Maternal and child medical care, including the provision of ART and antiretroviral prophylaxis, occurred at government clinics. Study staff provided urgent care and prompt referral as needed, including linkage to care for antiretroviral treatment. Participants also received support and counselling as appropriate from study staff; this included routine pre-and post-HIV test counselling, and infant feeding counselling. All counselling offered by staff occurred as private individual sessions in the study clinic and in accordance with Botswana policy. Maternal antiretroviral exposure during the current pregnancy was defined as receipt of at least 2 weeks of ART prior to delivery. Mothers chose infant feeding method after counselling by government and study staff, following the local standard of care. HIV testing occurred at enrollment for all women and again at delivery for women who had tested HIV-negative at antenatal enrollment. Women enrolled in the HIV-negative cohort had repeat HIV testing at the 24 months follow-up visit.
Data on sociodemographic factors, health, child feeding method where "breastfeeding" represents any breastfeeding, "formula feeding" represents exclusive formula feeding without any breastfeeding, and "never fed" represents infants neither breastfed or formula fed before dying. Psychosocial characteristics were collected shortly after enrollment and during follow-up from mothers using structured questionnaires. We administered previously validated screening instruments to assess for food insecurity using the Household Food Insecurity Access Scale, 17 maternal depression with the Beck Depression Inventory Fast Screen for Medical Patients, 18 social support with the Duke-University of North Carolina Functional Social Support Questionnaire, 19 and alcohol use with the Alcohol Use Disorders Identification Test and also asked about use of tobacco and illicit drugs. 20 All assessments were administered within 4 weeks of enrollment; the depression screen was also administered at 1, 12, and 24 months postpartum, and the other assessments were administered at 18 months postpartum.
Child health outcomes were ascertained through caregiver interview, physical assessment of the child, and review of the child's written medical records. Child HIV status was ascertained by DNA polymerase chain reaction (PCR) at birth, 4-6 weeks of age, and after the cessation of breastfeeding (for HIV exposed children); and HIV EIA at 18 months in all children, regardless of maternal HIV status. Positive DNA PCR tests were confirmed with a second DNA PCR and further confirmed by EIA at 18 months of age. HIV-infected children and those with unknown HIV status were excluded from this analysis.
Ethical Considerations
The Office of Human Research Administration at the T.H Chan Harvard School of Public Health and the Health Research Development Committee of the Botswana Ministry of Health provided institutional review board review and approval for the Tshipidi study (approval numbers 18093 and 00524 respectively). All enrolled women provided written informed consent prior to study participation.
Statistical Analyses
Our primary, prespecified outcome for this analysis was child mortality through 24 months of age, among liveborn HIVexposed uninfected vs HIV-unexposed children. We included as a secondary (composite) endpoint; the occurrence of either child hospitalization (for any reason) or death in these 2 groups of children. We also sought to evaluate (controlling for multiple potential confounders) biologic and social factors that may have been associated with early child morbidity and mortality, such as depression, food insecurity, and social Volume 203 • December 2018 support. Depression and social support scores were put into the models as continuous variables. Food insecurity was categorized as "none/mild" vs "moderate/severe" insecurity.
Kaplan-Meier curves with a log-rank test were used to assess the potential differences between HIV-exposed uninfected and HIV-unexposed children for both the primary and secondary endpoints. Twins were considered to be the same as singletons, as we did not account for clustering with multiple pregnancies in primary analyses but performed a sensitivity analysis excluding multiplets. Crude and adjusted risk factors for child mortality and morbidity were assessed using Cox proportional hazard models. Covariates were chosen for initial inclusion in the final multivariable model if P < .2 in the univariate analysis. Factors such as low birth weight and prematurity that were considered to be potential mediators between HIV exposure and child health outcome were excluded from the main adjusted models but included in subsequent sensitivity analyses. As HIV exposure and child feeding were nearly collinear (99% of HIV-unexposed children breastfed compared with 8% of HIV-exposed children), these factors could not be included simultaneously in adjusted models. Thus, we constructed different multivariable models that included HIV exposure and (separately) child feeding method. Children who had never been fed because they died prior to first feeding were excluded from all models containing child feeding method. All analyses were conducted using SAS v 9.4 (SAS Institute, Cary, North Carolina).
Results
A total of 910 live-born children (453 HIV-exposed, 457 HIVunexposed) were enrolled (Figure 1) . Seventeen live-born children who were born to HIV-infected mothers were excluded from the mortality analysis: 10 were excluded due to being HIVinfected and 7 were excluded as they had unknown HIV status. Thus, 893 children (436 HIV-exposed uninfected, 457 HIVunexposed) and their 878 mothers (15 mothers had twins) were included in the analyses presented here. We had vital status information at 24 months for 888 (99.4%) of these 893 children.
HIV-infected women were older at delivery than HIVuninfected women (median 29 vs 25 years of age, respectively), and had median CD4 count of 410 cells/mm 3 ; 32% took 3-drug ART during pregnancy, 67% took zidovudine, and only 1% of women took fewer than 2 weeks of ART antepartum ( Table I) . HIV-exposed uninfected and HIV-unexposed children had similar median gestational age at delivery (39 weeks, IQR: 39-42).
Of the 893 liveborn children included, 30 (3.4%) died by 24 months: 22 (5.0%) HIV-exposed uninfected and 8 (1.8%) HIV-unexposed. The proportion of children who died through 24 months of follow-up by feeding and HIV exposure status are presented in Table II .
In univariate analyses, HIV-exposed uninfected children were 3 times more likely to die by 24 months compared with HIVunexposed children (hazard ratio [HR] 2.95, 95% CI 1.31-6.62). This increased from 2.9 to 3.6 in sensitivity analyses that included only singletons (HR 3.6, 95% CI 1.46-9.07). Exclusively formula-fed children had higher rates of mortality than breastfed children (4.5% vs 1.2%, HR 3.71 95% CI 1.64-8.40). Mortality among children was highest in the first month of life: 15 (50.0%) deaths occurred within the first month of life (54.6% of deaths in HIV-exposed uninfected and 37.5% of deaths in HIV-unexposed). Mortality with HIV exposure was higher for deaths occurring during the neonatal period (HR 4.2) vs deaths occurring after the neonatal period (HR 2.2). In addition, both neonatal deaths and later deaths in babies were associated with being born preterm. The Kaplan-Meier curves of time to mortality by HIV exposure group and feeding method are shown in Figure 2 (available at www.jpeds.com).
On univariate analysis, predictors of 24-month mortality overall (among HIV-exposed uninfected and HIV-unexposed children combined) included being born to a mother with HIV (as noted above), living in a rural setting (HR 1.68, 95% CI 0.81 -3.46), formula feeding (HR 3.72, 95% CI 1.48-9.38), or (Table III) . Maternal depression or alcohol use during pregnancy, lower socioeconomic status, food insecurity, and lower social support were not associated with higher risk of child mortality. When the univariate analysis was restricted to HIV-exposed uninfecteds, lower socioeconomic status (indicated by households with no primary cooking method or those using firewood as their primary cooking source) had a borderline association with higher 24-month infant mortality (HR 1.84, CI 0.77-4.38). HIV exposure and feeding method were collinear in the study (99% of HIV-unexposed children breastfed compared with 8% of HIV-exposed children), and these factors could, therefore, not be simultaneously included in multivariable models. Instead, 2 different multivariable models, 1 with HIV exposure and the other with child feeding, were run (Table III) . Multivariable analysis of all significant predictors-excluding covariates on the causal pathway between maternal HIV infection and infant death (ie, potential mediators such as preterm birth, low birth weight, presence of congenital anomalies)-showed that HIV exposure (aHR 3.27, 95% CI 1.44-7.40), formula feeding (aHR 3.83, 95% CI 1.52-9.70), and rural dwelling (aHR 1.48, 95% CI 0.64-3.43), were independently associated with increased risk for mortality. In primary multivariable analysis among only HIV-exposed uninfected children, no predictor remained significant.
In secondary multivariable models that included predictors potentially on the causal pathway, both low birth weight and presence of a congenital anomaly remained associated with 24-month mortality among children overall, as well as in HIVexposed uninfected children only. Other findings did not differ substantially from the analyses that excluded these potential mediators.
In the secondary analysis of hospitalization and/or mortality in all children by HIV exposure, HIV-exposed uninfected children had shorter times to first hospitalization or death compared with HIV-unexposed children (log rank P < .0001) as seen in Figure 2 . Gastroenteritis, pneumonia, and other respiratory illness were the leading cause of hospitalization and death observed (Table IV; available at www.jpeds.com).
HIV exposure (aHR 1.74, 95% CI 1.23-2.47), formula feeding (aHR 1.65, 95% CI 1.17-2.33), no formal or primary maternal education (aHR 1.38, 95% CI 0.85-2.23), or being a male child (aHR 1.34, CI 0.97-1.85) were each associated with risk of hospitalization and/or death through 24 months in multivariable models constructed in a similar manner as for the mortality-only endpoint. As highlighted above HIV exposure and feeding were collinear in the study, hence, both factors were not simultaneously included in multivariable models. When analysis was limited to only HIV-exposed uninfected children, use of fire as the primary cooking method as compared with stove (aHR 1.46, 95% CI 0.92-2.33) was the only predictor of hospitalization and/or death through 24 months.
Discussion
We found that HIV exposure and formula feeding remain the strongest risk factors for mortality by 24 months of age in Botswana, even after controlling for multiple potential socioeconomic and psychosocial predictors of adverse child outcomes. Despite a healthier population of HIV-infected mothers whose enhanced access to treatment in the modern era has resulted in higher median CD4 counts, HIV-uninfected children who were exposed in utero to HIV were 3 times more likely than their unexposed peers to die by 2 years after birth. These findings are broadly consistent with prior studies, which have documented 2-to 6-fold higher mortality among HIV-exposed uninfected children, 6, 7, [21] [22] [23] [24] and further highlight the need to better understand and mitigate the mechanisms underlying this risk. Formula-fed children were nearly 4 times more likely to die by 24 months than breastfed children; however, the collinearity of HIV status and feeding method unfortunately prevented us from determining the independent contributions of HIV exposure and feeding method to child outcomes. Mortality was also significantly greater among children born preterm or with low birth weight and children born with a congenital anomaly. Finally, one-half of all observed mortality occurred within the first month of life, which, thus, represents a particularly vulnerable period that may lend itself to further intervention aimed at improving child health outcomes.
Unique to this study was the richness of the sociodemographic and maternal psychosocial data that we collected. In prior studies, it has not been possible to exclude the role of these potential confounders in the association between HIV exposure and higher HIV-exposed uninfected mortality. In addition to financial status and maternal education, we examined a range of previously unmeasured factors such as household food insecurity, social support, maternal depression, and alcohol/substance use. We did not find any of these factors to be associated with increased risk for morbidity or mortality. This is an important negative result and suggests that the excess morbidity and mortality observed in HIV-exposed uninfected children are most likely driven by biologic and immunologic factors related to HIV exposure and replacement feeding. In addition, our study was conducted in the context of a healthier population of HIV-infected pregnant women, with higher ART coverage during pregnancy; nonetheless, the excess mortality among HIV-exposed uninfected children persisted in this population and was likely exacerbated by formula feeding. Overall, our findings further highlight the heightened vulnerability of children exposed to HIV. Morbidity and mortality trends observed among HIV-exposed uninfected children in this and prior studies [25] [26] [27] are of public health significance and warrant global attention. To preserve the gains of successful PMTCT programs, it is imperative to recognize HIVexposed uninfected infants as a vulnerable group and provide prompt and appropriate medical care and support aimed at reducing their risk of severe illness and mortality. Furthermore, although we cannot disentangle the effects of HIV exposure vs formula feeding on child morbidity and mortality, both are probably contributing. Considering both the documented beneficial effects of breastfeeding, 25, [28] [29] [30] the risks of replacement feeding, 29 ,31 the low risk of HIV MTCT from mothers who are taking 3-drug ART, 32, 33 and revised feeding guidelines that promote breastfeeding in the region, 34, 35 it is important for HIV-exposed uninfected children to breastfeed in regions with substantial child morbidity and mortality, provided their mothers are able to maintain appropriate virologic suppression while receiving ART.
Our study has limitations. Most HIV-exposed uninfected children in the study were exclusively formula fed and nearly all HIV-unexposed children breastfed, which made separating the effects of HIV exposure from feeding method impossible. Furthermore, information on maternal HIV-1 viral load was not systematically available. 
